Objective To provide theoretical basis of standardized management and treatment for polycystic ovarian syndrome(PCOS) patients through the study of Diane 35 vs Diane 35 plus metformin on PCOS women under comprehensive management. Methods Sixty patients with PCOS were randomly divided into two groups, Diane-35-only group and Diane-35 plus metformin(the combination) group, each with 30 cases. Their resting-energy-consumption and body-composition-measurement on movement functionality were analyzed to offer individualized nutrition and exercise guidance. Three Diane-35 cycles were administered; metformin was added in one group. We selected the data of patients' height, weight, waist circumference, hip circumference, body fat percentage, acne score, hirsutism score; serum hormone level were tested between 2nd and 5th days of menstrual cycle, such as follicle-stimulating hormone, luteinizing hormone, testosterone, blood glucose, blood lipids, insulin, etc. Results 1 After three months' treatment, body mass index, acne score, LH levels and T levels dropped in both groups, while HDL-C concentration elevated, the difference was statistically significant(P<0.05); the hairy score decreased slightly(P>0.05); total cholesterol and triglycerides concentration elevated(P>0.05). 2 After three months' treatment, the body fat content, fasting glucose and insulin resistance index in combined treatment group decreased, the difference was statistically significant(P<0.05). 3 After three months' treatment, fasting blood sugar was elevated and fasting insulin concentration dropped in Diane-35 treatment group(P>0.05). 4 The body mass index, fasting blood glucose changes were significant different between two groups(P<0.05), while the rest indicators were not significantly different(P>0.05). Conclusion Under the individualized nutrition and exercise guidance, Diane-35 only group or Diane-35 plus metformin group could both effectively reduce serum testosterone levels, improve acne symptoms, but not hirsutism. The combination group can reduce the fat content in patients with PCOS, improve glucose and lipid metabolism, and Diane-35 alone does not worsen glucose and lipid metabolism in patients with PCOS.